Markus Bauer Verified Lawyer
Experience
Dr. Markus Bauer advises both German and international clients on national and cross-border corporate acquisitions, the formation and administration of joint ventures, private equity transactions, and the structuring or restructuring of corporations and corporate groups. A further focus of his work is advising management boards, managing directors, and supervisory boards of predominantly medium-sized companies on their respective duties and the development of compliance programs, as well as representing shareholders in shareholder disputes. For many years, he has lectured on Mergers & Acquisitions as part of an LL.M. program at the Frankfurt University of Applied Sciences.
Specialty
Compliance, corporate law, mergers and acquisitions law.
Education
(No information available in search results.)
Achievements and Recognition**
- Best Lawyers 2025 award in Corporate Law and Mergers & Acquisitions Law (source)
- Recognized in Best Lawyers in Germany since 2021 (2026 edition) for Corporate Law and Mergers and Acquisitions Law (source)
- Listed among Germany's top lawyers in Best Lawyers (Corporate/M&A category) by Handelsblatt (source)
- Often recommended in M&A, JUVE manual 2024/2025 (source)
- Teaching appointment at Frankfurt University of Applied Sciences in Mergers & Acquisitions (source)
- Honorary member of the Association Internationale des Jeunes Avocats (AIJA) (source)
- Former Chairman of Legalink (immediate past Chairman as of 2023 Annual Report); hosted 2023 inaugural general meeting in Frankfurt (source)
- Co-author of commentary on §§ 43-49 Geldwäschegesetz (Money Laundering Act) in Brock, Kommentar zum Geldwäschegesetz, 1st ed. 2024 (source)
- Advised Vision Group on strategic partnership with KKR (source)
- Advised Merz-Group on investment in Brooklyn Soap (source)
- Advised Keller Group on sale of Wannenwetsch to DEUBIS Group (source)
- Advised CureVac AG during its IPO on NASDAQ (source)
- Advised CureVac AG in private financing round of ~560 million euros (source)
- Advised Merz Pharma on sale of SENATOR Group to Perusa private equity (source)